From DCAT Value Chain Insights (VCI)
Mylan N.V. reports that John Sheehan has advised the company of his intention to retire from his position as chief financial officer (CFO) of Mylan, effective April 1, 2016. Mylan's board of directors has initiated a search to identify a replacement for Mr. Sheehan.
Mylan Executive Chairman Robert J. Coury commented, "John has served with distinction as Mylan's CFO for the past six years, contributing significantly to Mylan's success during this time and helping to ensure that we delivered consistently strong financial performance. Importantly, John has demonstrated all of the qualities that make Mylan so special: dedication to our mission, passionate leadership and an unwavering commitment to doing what is right. I am extremely grateful to John for his service to Mylan and for helping to position the company so well for the future."
Mylan's CEO Heather Bresch added, "John has been a valued partner since he joined Mylan in 2010 and, during the next several months, he will help to ensure a smooth transition of his CFO responsibilities while we identify a successor. We have in place the financial strength and flexibility, strong business momentum and deep leadership team to ensure Mylan's continued growth and success. We thank John for his many contributions and wish him all the best in the future."
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription